UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 29,705 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lowered its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 5.3% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 531,558 shares of the biotechnology company's stock after selling 29,705 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.70% of Axon Enterprise worth $315,916,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Ritholtz Wealth Management grew its position in shares of Axon Enterprise by 22.7% in the fourth quarter. Ritholtz Wealth Management now owns 616 shares of the biotechnology company's stock valued at $366,000 after purchasing an additional 114 shares during the last quarter. HB Wealth Management LLC lifted its position in shares of Axon Enterprise by 5.0% during the 4th quarter. HB Wealth Management LLC now owns 1,441 shares of the biotechnology company's stock worth $856,000 after purchasing an additional 68 shares during the last quarter. Koshinski Asset Management Inc. bought a new stake in Axon Enterprise during the 4th quarter valued at approximately $574,000. Ballentine Partners LLC grew its holdings in Axon Enterprise by 64.4% in the 4th quarter. Ballentine Partners LLC now owns 1,205 shares of the biotechnology company's stock valued at $716,000 after buying an additional 472 shares during the last quarter. Finally, Crossmark Global Holdings Inc. grew its holdings in Axon Enterprise by 11.6% in the 4th quarter. Crossmark Global Holdings Inc. now owns 4,064 shares of the biotechnology company's stock valued at $2,415,000 after buying an additional 422 shares during the last quarter. Institutional investors and hedge funds own 79.08% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the company. Needham & Company LLC upped their price target on Axon Enterprise from $600.00 to $750.00 and gave the stock a "buy" rating in a report on Thursday, May 8th. Northcoast Research cut shares of Axon Enterprise from a "buy" rating to a "neutral" rating in a research note on Wednesday, February 19th. The Goldman Sachs Group increased their price target on shares of Axon Enterprise from $730.00 to $830.00 and gave the company a "buy" rating in a report on Wednesday, May 14th. JMP Securities restated an "outperform" rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. Finally, Craig Hallum lowered shares of Axon Enterprise from a "buy" rating to a "cautious" rating in a research report on Monday, March 10th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and ten have assigned a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $652.73.

Axon Enterprise Price Performance

Shares of NASDAQ:AXON traded up $15.38 during midday trading on Tuesday, reaching $746.75. 126,401 shares of the company's stock were exchanged, compared to its average volume of 737,637. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The company's 50 day simple moving average is $606.52 and its two-hundred day simple moving average is $606.73. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $748.80. The firm has a market capitalization of $58.14 billion, a PE ratio of 192.96, a price-to-earnings-growth ratio of 5.17 and a beta of 1.24.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 EPS for the quarter, topping analysts' consensus estimates of $1.34 by $0.07. The firm had revenue of $603.63 million during the quarter, compared to analysts' expectations of $585.67 million. Axon Enterprise had a net margin of 15.37% and a return on equity of 7.50%. The company's revenue for the quarter was up 31.3% compared to the same quarter last year. During the same quarter last year, the company earned $1.15 earnings per share. Equities research analysts expect that Axon Enterprise, Inc. will post 5.8 earnings per share for the current fiscal year.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, CFO Brittany Bagley sold 3,400 shares of Axon Enterprise stock in a transaction on Tuesday, May 13th. The stock was sold at an average price of $700.00, for a total transaction of $2,380,000.00. Following the completion of the transaction, the chief financial officer now directly owns 131,833 shares of the company's stock, valued at approximately $92,283,100. This trade represents a 2.51% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Patrick W. Smith sold 10,000 shares of the business's stock in a transaction on Monday, April 21st. The shares were sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the completion of the sale, the chief executive officer now owns 3,063,982 shares in the company, valued at $1,657,583,622.18. This represents a 0.33% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 34,969 shares of company stock valued at $23,127,314 in the last 90 days. 4.40% of the stock is owned by corporate insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.